This story has been updated from a previous version. 

NEW YORK, July 16 – PerkinElmer has agreed to acquire Packard BioScience in a stock deal valued at about $650 million.    

According to a statement released by the companies on Sunday, PerkinElmer seemed particularly interested in acquiring Packard BioScience for its liquid handling and sample preparation capabilities.    

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.